⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vetter Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Vetter Pharma
↗Ravensburg, Germany
Vetter Pharma is a leading, family-owned global Contract Development and Manufacturing Organization (CDMO) specializing in the aseptic fill-and-finish of injectable drugs. The company provides comprehensive services ranging from early-stage clinical development and drug product development to commercial manufacturing, device assembly, and secondary packaging for vials, syringes, and cartridges.
With over 75 years of history, Vetter operates state-of-the-art facilities in Germany, Austria, and the United States. The company is a critical partner to the global pharmaceutical and biotechnology industry, supporting the production of complex biologics and other high-value injectable therapies for patients worldwide.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:€1.259 billion (2025)
Founded:1950
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (CDMO Service Provider)
Modalities:Small molecule, mAb, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:130
EMA Approvals:130
CORPORATE STRUCTURE
Key Partnerships:Groninger (Filling equipment technology partnership)
COMPETITION
Position:Leader
Competitors:Catalent, Lonza, Thermo Fisher Scientific (Patheon), Recipharm
LEADERSHIP
Key Executives:
Henryk Badack - Managing Director
Titus Ottinger - Managing Director
Carsten Press - Managing Director
LINKS
Website:vetter-pharma.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vetter Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.